Krsnaa Diagnostics Limited (KRSNAA.NS)
INR 910.0
(-0.9%)
INR 910.0
(-0.9%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 6.19 Billion INR | 0.0% |
| 2022 | 4.87 Billion INR | 6.95% |
| 2021 | 4.55 Billion INR | 14.88% |
| 2020 | 3.96 Billion INR | 53.41% |
| 2019 | 2.58 Billion INR | 23.51% |
| 2018 | 2.09 Billion INR | 94.51% |
| 2017 | 1.07 Billion INR | 89.09% |
| 2016 | 568.89 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.86 Billion INR | 9.46% |
| 2024 Q1 | 1.7 Billion INR | 27.78% |
| 2023 Q3 | 1.58 Billion INR | 1.85% |
| 2023 Q4 | 1.33 Billion INR | -15.85% |
| 2023 FY | 4.87 Billion INR | 0.0% |
| 2023 Q1 | 1.39 Billion INR | 4.77% |
| 2023 Q2 | 1.55 Billion INR | 11.37% |
| 2022 Q1 | 1.12 Billion INR | 4.26% |
| 2022 Q4 | 1.33 Billion INR | 12.81% |
| 2022 FY | 4.87 Billion INR | 6.95% |
| 2022 Q3 | 1.18 Billion INR | -3.94% |
| 2022 Q2 | 1.22 Billion INR | 8.93% |
| 2021 Q1 | 1.32 Billion INR | 38.12% |
| 2021 FY | 4.55 Billion INR | 14.88% |
| 2021 Q4 | 1.08 Billion INR | 1.67% |
| 2021 Q3 | 1.06 Billion INR | -1.66% |
| 2021 Q2 | 1.08 Billion INR | -18.27% |
| 2020 FY | 3.96 Billion INR | 53.41% |
| 2020 Q4 | 959.12 Million INR | 0.0% |
| 2019 FY | 2.58 Billion INR | 23.51% |
| 2019 Q4 | 688.08 Million INR | 0.0% |
| 2018 FY | 2.09 Billion INR | 94.51% |
| 2017 FY | 1.07 Billion INR | 89.09% |
| 2016 FY | 568.89 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Dr. Lal PathLabs Limited | 22.26 Billion INR | 72.172% |
| Metropolis Healthcare Limited | 12.07 Billion INR | 48.694% |
| Thyrocare Technologies Limited | 5.71 Billion INR | -8.35% |
| Vijaya Diagnostic Centre Limited | 5.47 Billion INR | -13.112% |
| Vimta Labs Limited | 3.18 Billion INR | -94.693% |